Search results for "EPO"

showing 10 items of 6062 documents

Symptomatic remission in schizophrenia patients: relationship with social functioning, quality of life, and neurocognitive performance.

2011

Abstract Purpose To investigate whether symptomatic remission relates to better outcomes in schizophrenia. Methods Seventy-six schizophrenia patients were assessed using measures of cross-sectional symptomatic remission, social functioning, subjective quality of life (QoL), and cognition. Results Most patients (53; 69.7%) were not in remission. Remitted patients presented significantly better social functioning, better self-reported QoL, insight, and lower levels of depressive symptoms. They also showed a non-significant trend for better executive function, processing speed and verbal memory. Conclusions Symptomatic remission may be a good indicator of better clinical status, social functio…

AdultMalemedicine.medical_specialtyCross-sectional studyNeuropsychological TestsStatistics NonparametricQuality of lifeRecurrencemedicineHumansCognitive skillPsychiatryBiological PsychiatryDepression (differential diagnoses)Psychiatric Status Rating ScalesAnalysis of VarianceCognitionMiddle Agedmedicine.diseasePsychiatry and Mental healthCross-Sectional StudiesSchizophreniaQuality of LifeSchizophreniaFemaleSchizophrenic PsychologySelf ReportVerbal memoryPsychologyCognition DisordersNeurocognitiveSocial AdjustmentClinical psychologySchizophrenia research
researchProduct

Association of mental distress with smoking status in the community: Results from the Gutenberg Health Study.

2013

Abstract Background Exposition to tobacco smoke is among the major modifiable risk factors in the general population. There is strong evidence for a close association between smoking exposure and mental disorders. Methods Cross-sectional associations of different conditions of smoking status (former, current, and second hand smoking (SHS)) with indicators of mental distress were analyzed in a sample of N =5000 participants (aged 35–74 years) of the population-based survey “Gutenberg Health Study”. Results In the general population clinically significant depression (OR 1.59, 95%CI 1.17–2.17) and a previous diagnosis of depression (OR 1.50, 95%CI 1.16–1.94) were associated with current smokin…

AdultMalemedicine.medical_specialtyCross-sectional studyPopulationAlcohol abuseTobacco smokeMental distressResidence CharacteristicsRisk FactorsmedicinePrevalenceHumanseducationPsychiatryDepression (differential diagnoses)Agededucation.field_of_studybusiness.industryDepressionPublic healthSmokingMiddle Agedmedicine.diseaseHealth SurveysPsychiatry and Mental healthClinical PsychologyDistressCross-Sectional StudiesFemaleTobacco Smoke PollutionSelf ReportbusinessStress PsychologicalJournal of affective disorders
researchProduct

Associations between self-reported physical activity and oral health: a cross-sectional analysis in 17,777 Spanish adults

2020

Background The aim of this study was to assess the association between levels of physical activity and oral health in adults residing in Spain. Methods Cross-sectional data from the Spanish National Health Survey 2017 were analysed (n = 17,777 adults aged ≥15 years; 52.0% females). The International Physical Activity Questionnaire (IPAQ) short form was used to measure physical activity. Oral health was self-reported through eight variables. Covariates included were sex, age, marital status, education, obesity, smoking and alcohol consumption. Results Dental caries (19.8% vs 27.8%), dental extraction (72.7% vs 75.4%), gingival bleeding (15.5% vs 19.1%), tooth movement (4.3% vs 5.9%) and miss…

AdultMalemedicine.medical_specialtyCross-sectional studymedicine.medical_treatmentPhysical activityOral HealthOral healthDental Caries03 medical and health sciences0302 clinical medicineInternal medicinemedicinePrevalenceHumans030212 general & internal medicineGeneral DentistryExerciseNational healthMissing toothbusiness.industry030206 dentistrymedicine.diseaseObesitystomatognathic diseasesCross-Sectional StudiesDental extractionSpainMarital statusFemale[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieSelf Reportbusiness
researchProduct

A discrete-choice experiment to assess patients’ preferences for osteoarthritis treatment: An ESCEO working group

2020

Objective: To evaluate the preferences of patients with osteoarthritis for treatment.Methods: A discrete-choice experiment was conducted among adult OA patients who were presented with 12 choice sets of two treatment options and asked in each to select the treatment they would prefer. Based on literature reviews, expert consultation, patient survey and expert meeting, treatment options were characterized by seven attributes: improvement in pain, improvement in walking, ability to manage domestic activities, ability to manage social activities, improvement in overall energy and well-being, risk of moderate/severe side effects and impact on disease progression. Random parameters logit model w…

AdultMalemedicine.medical_specialtyDiscrete choice experimentOsteoarthritisOutcomes03 medical and health sciences0302 clinical medicinePHYSICIANSRheumatologySurveys and QuestionnairesOsteoarthritisMedicineHumans030212 general & internal medicineAgedOutcome030203 arthritis & rheumatologyddc:616HIPbusiness.industryDisease progressionDiscrete-choice experimentTreatment optionsPatient PreferencePatient preferencesmedicine.diseaseLatent class modelPreferenceEuropeInstitutional repositoryAnesthesiology and Pain MedicineLogistic ModelsPhysical therapyPatient surveyFemaleKNEEOsteoarthritiHEALTHbusiness
researchProduct

Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma

2018

Background Mepolizumab has demonstrated favorable safety and efficacy profiles in placebo-controlled trials of 12 months' duration or less; however, long-term data are lacking. Objective We sought to evaluate the long-term safety and efficacy of mepolizumab in patients with severe eosinophilic asthma (SEA). Methods COLUMBA (Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects, NCT01691859 ) was an open-label extension study in patients with SEA previously enrolled in DREAM (Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma, NCT01000506 ). Patients received 100 mg of subcutaneous mepolizumab every 4 weeks plus standard of care until a protocol-def…

AdultMalemedicine.medical_specialtyDrug-Related Side Effects and Adverse ReactionsExacerbationInjections Subcutaneous[SDV]Life Sciences [q-bio]ImmunologyEosinophilic asthmaAntibodies Monoclonal HumanizedPlacebos03 medical and health sciences0302 clinical medicineDouble-Blind MethodSurveys and QuestionnairesInternal medicineEosinophiliamedicineHumansImmunology and AllergyIn patientAnti-Asthmatic Agents030212 general & internal medicineAdverse effectRespiratory Tract InfectionsComputingMilieux_MISCELLANEOUSAsthmabusiness.industryMiddle Agedmedicine.diseaseAsthma3. Good healthEosinophils[SDV] Life Sciences [q-bio]Treatment Outcome030228 respiratory systemAsthma Control QuestionnaireBronchitisFemaleInterleukin-5businessMepolizumabmedicine.drug
researchProduct

Effects of morning vs. evening combined strength and endurance training on physical performance, sleep and well-being

2019

The aim of the present study was to examine how combined strength and endurance training in the morning and evening influences the adaptations in strength and endurance performance, perception of time management, psychological well-being and sleep. The combined training period lasted for 24 weeks and the participants were divided into the morning training (MG, n = 18), evening training (EG, n = 24) and control groups (CG, n = 10). Isometric leg press force (iLP), maximal oxygen consumption (VO2max), sleep behavior, fatigue, time management, motivation, self-esteem and health-related quality of life (HRQoL) were assessed. Morning to evening difference in iLP was observed in both MG and EG at…

AdultMalemedicine.medical_specialtyEveningkestävyysharjoitteluPhysiology030209 endocrinology & metabolismelämänlaatuIsometric exercisetime managementuni (lepotila)03 medical and health scienceshenkinen hyvinvointi0302 clinical medicinemotivationEndurance trainingPhysiology (medical)maksimaalinen hapenottomedicineHumansMuscle StrengthMuscle Skeletalta315Leg pressajanhallintaMorningmotivaatiobusiness.industryVO2 maxResistance TrainingPhysical Functional PerformanceAdaptation PhysiologicalCircadian RhythmEndurance Trainingfyysinen kuntoPhysical performancePhysical EndurancePhysical therapyFemalevoimaharjoitteluSleep (system call)Sleepbusiness030217 neurology & neurosurgerylihasvoimaChronobiology International
researchProduct

Cytosolic epoxide hydrolase in humans: development and tissue distribution.

1988

Cytosolic epoxide hydrolase activity was measured towards trans-stilbene oxide in 41 human adult livers, in 40 fetal livers, in 17 placentas and in fetal and adult lungs, kidneys and gut. The cytosolic epoxide hydrolase activity was measurable in all specimens investigated. The rate of formation of trans-stilbene glycol (pmol/min per mg protein, mean +/- SD) was 55.2 +/- 89.6 (fetal liver). 303.2 +/- 73.2 (adult liver) and 18.8 +/- 13.1 (placenta) In the fetal extrahepatic tissues, the cytosolic epoxide hydrolase activity was 70.0 +/- 9.4 (adrenals), 47.6 +/- 7.2 (gut), 69.4 +/- 22.5 (kidneys) and 43.2 +/- 19.2 (lungs) pmol/min per mg protein, whereas in the adult tissues it was 131.2 +/- 6…

AdultMalemedicine.medical_specialtyHealth Toxicology and MutagenesisBiologyToxicologyCytosolFetusCytosolic epoxide hydrolase activityPregnancyInternal medicinePlacentamedicineAnimalsHumansTissue DistributionTissue distributionEpoxide hydrolaseAgedEpoxide HydrolasesFetusUrinary bladderRats Inbred StrainsGeneral MedicineMiddle AgedRatsCytosolmedicine.anatomical_structureEndocrinologyLiverFemaleAdult liverArchives of toxicology
researchProduct

New mesh shape and improved implantation procedure to simplify and standardize open ventral hernia repair: a preliminary report.

2010

Introduction Issues in ventral hernia repair are represented by the need for mesh fixation and how to assure a sufficient mesh overlap of the defect. Aiming to resolve these problems, this study describes a modified technique for ventral and incisional hernia repair based upon a newly developed mesh with a special design. This new type of implant allows broader coverage of the abdominal wall and results in tension- and fixation-free repair. Materials and methods A unique geometrically shaped mesh consisting of a large central body and radiating arms was used to repair ventral or incisional hernia. The mesh was intended not to be point-fixated. The friction of the straps passing through the …

AdultMalemedicine.medical_specialtyHerniaFrictionIncisional herniaAbdominal wallProsthesis ImplantationHematomaPreliminary reportProstheseRecurrencemedicineHumansSurgical Wound InfectionHerniaHerniorrhaphyFixation (histology)AgedSurgical fixation deviceVentral hernia repairbusiness.industryAbdominal WallImplantMiddle AgedSurgical Meshmedicine.diseaseHernia VentralSurgerySettore MED/18 - Chirurgia Generalemedicine.anatomical_structureSeromaVentralSurgeryFemaleImplantbusinessFollow-Up StudiesHernia : the journal of hernias and abdominal wall surgery
researchProduct

Sensitivity to heat in MS patients: a factor strongly influencing symptomology -- an explorative survey

2011

Published version of an article to be found in BMC Neurology 2011, 11:27, http://dx.doi.org/10.1186/1471-2377-11-27 Background: Many individuals diagnosed with Multiple Sclerosis (MS) are sensitive to increased body temperature, which has been recognized as correlating with the symptom of fatigue. The need to explore this association has been highlighted. The aim of this study was to investigate the occurrence of heat sensitivity and its relations to disease course, disability, common MS-related symptoms and ongoing immunosuppressive treatments among individuals 65 years of age or younger diagnosed with MS. Methods: A cross-sectional designed survey was undertaken. A questionnaire was sent …

AdultMalemedicine.medical_specialtyHot TemperatureMultiple SclerosisCross-sectional studyClinical NeurologyLogistic regressionSeverity of Illness Indexlcsh:RC346-429Internal medicineSeverity of illnessLinear regressionmedicineHumansNeurochemistryThermosensingFatiguelcsh:Neurology. Diseases of the nervous systemAgedbusiness.industryMEDICINEMultiple sclerosisGeneral MedicineMiddle Agedmedicine.diseaseHealth SurveysChecklistCross-Sectional StudiesMEDICINVDP::Medical disciplines: 700::Clinical medical disciplines: 750::Neurology: 752Mann–Whitney U testPhysical therapyDisease ProgressionFemaleNeurology (clinical)Self ReportbusinessImmunosuppressive AgentsResearch Article
researchProduct

Use of Biologics to Treat Relapsing and/or Refractory Eosinophilic Granulomatosis With Polyangiitis: Data From a European Collaborative Study.

2021

OBJECTIVE To describe the efficacy and safety of biologics for the treatment of eosinophilic granulomatosis with polyangiitis (EGPA). METHODS A retrospective European collaborative study was conducted in patients with EGPA who received treatment with biologics for refractory and/or relapsing disease. RESULTS Among the 147 patients with EGPA included in the study, 63 received rituximab (RTX), 51 received mepolizumab (MEPO), and 33 received omalizumab (OMA). At the time of inclusion, the median Birmingham Vasculitis Activity Score (BVAS) was 8.5 (interquartile range [IQR] 5-13) in the RTX group, while the median BVAS in the OMA group was 2 (IQR 1-4.5) and the median BVAS in the MEPO group was…

AdultMalemedicine.medical_specialtyImmunologyBirmingham Vasculitis Activity ScoreOmalizumabOmalizumabChurg-Strauss SyndromeAntibodies Monoclonal Humanized03 medical and health sciences0302 clinical medicineRheumatologyInterquartile rangeRecurrenceInternal medicinemedicineImmunology and AllergyHumansImmunologic Factors030212 general & internal medicineTreatment FailureAdverse effectGlucocorticoidsAgedRetrospective Studies030203 arthritis & rheumatologyBiological Productsbusiness.industryMiddle Agedmedicine.diseaseAsthmaTreatment OutcomeRituximabFemaleVasculitisbusinessGranulomatosis with polyangiitisRituximabMepolizumabmedicine.drugArthritisrheumatology (Hoboken, N.J.)References
researchProduct